Results 281 to 290 of about 789,487 (311)

Evaluating Preclinical Efficacy

Science Translational Medicine, 2011
Translation of modern type 1 diabetes treatments from mouse to humans depends on implementation of therapeutic efficacy standards.
openaire   +2 more sources

Preclinical

2023
openaire   +1 more source

Preclinical Carcinoma of the Cervix

American Journal of Obstetrics and Gynecology, 1957
J P, LATOUR, L B, BROWN, L A, TURNBULL
openaire   +2 more sources

Acadesine: Preclinical Overview

1995
Acadesine (aica riboside) is the first in a new class of drugs termed adenosine regulating agents (ARAs). Acadesine and other drugs in this class elevate adenosine in a site and event specific manner at times and sites of pathology where there is net ATP breakdown but not in healthy settings or tissues. Acadesine and its 5’ monophosphate (ZMP) elevates
openaire   +2 more sources

Preclinical Cushing Disease

Archives of Internal Medicine, 2001
T, Takao, T, Mimoto, M, Yamamoto, K, Hashimoto   +3 more
openaire   +2 more sources

Systemic Inflammation in Preclinical Ulcerative Colitis

Gastroenterology, 2021
Marieke Pierik, Daisy M A E Jonkers, Jørgen Jahnsen   +2 more
exaly  

Incidence of Preclinical Heart Failure in a Community Population

Journal of the American Heart Association, 2022
Horng H Chen, Kathleen A Young, Christopher G. Scott   +2 more
exaly  

Preclinical Medicine: Preclinical States and Prevention of Disease

The American Journal of the Medical Sciences, 1940
openaire   +1 more source

Preclinical development of molecular-targeted agents for cancer

Nature Reviews Clinical Oncology, 2010
Alberto Ocana, Lillian Siu, Atanasio Pandiella   +2 more
exaly  

Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models

Nature Reviews Drug Discovery, 2019
Richard J Weaver, Brian Kevin Park, Ursula Klingmüller   +2 more
exaly